• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Long-term clopidogrel administration following severe coronary injury reduces proliferation and inflammation via inhibition of nuclear factor-kappaB and activator protein 1 activation in pigs.

作者信息

Pels K, Schwimmbeck P L, Rosenthal P, Loddenkemper C, Dang-Heine C, Rauch U, Martens H, Schultheiss H-P, Dechend R, Deiner C

机构信息

Charité- Campus Benjamin Franklin, Berlin, Germany.

出版信息

Eur J Clin Invest. 2009 Mar;39(3):174-82. doi: 10.1111/j.1365-2362.2009.02089.x.

DOI:10.1111/j.1365-2362.2009.02089.x
PMID:19260946
Abstract

BACKGROUND

The optimal duration of clopidogrel treatment following percutaneous coronary intervention (PCI) and the patient population that would benefit most are still unknown. In a porcine coronary injury model, we tested two different durations of clopidogrel treatment on severely or moderately injured arteries and examined the arterial response to injury. To understand the molecular mechanism, we also investigated the effects on transcription factors nuclear factor-kappaB (NF-kappaB) and activator protein 1 (AP-1).

MATERIALS AND METHODS

In 24 cross-bred pigs, one coronary artery was only moderately injured by percutaneous transluminal coronary angioplasty (PTCA) and one coronary artery was severely injured by PTCA and subsequent beta-irradiation (Brachy group). Animals received 325 mg aspirin daily for 3 months and 75 mg clopidogrel daily for either 28 days [short-term (ST) clopidogrel group] or 3 months [long-term (LT) clopidogrel group].

RESULTS

After 3 months, the number of proliferating cells per cross-section differed significantly between ST and LT in both injury groups (PTCA(ST) 90.2 +/- 10.3 vs. PTCA(LT )19.2 +/- 4.7, P < 0.05; Brachy(ST) 35.8 +/- 8.4 vs. Brachy(LT) 7.5 +/- 2.0, P < 0.05). Similar results were seen for inflammatory cells (CD3(+) cells): PTCA(ST) 23.5 +/- 3.55 vs. PTCA(LT )4.67 +/- 0.92, P < 0.05; Brachy(ST) 83.17 +/- 11.17 vs. Brachy(LT) 20 +/- 4.82, P < 0.05). Long-term administration also reduced the activity of NF-kappaB and AP-1 by 62-64% and 42-58%, respectively. However, the effects of different durations of clopidogrel administration on artery dimensions were not statistically significant.

CONCLUSIONS

Regarding inflammation and transcription factor activity at the PCI site, long-term clopidogrel administration is superior to short-term administration, especially in severely injured arteries. Transferring our results to the human situation, patients with more severely diseased arteries may benefit from a prolonged clopidogrel medication after PCI.

摘要

相似文献

1
Long-term clopidogrel administration following severe coronary injury reduces proliferation and inflammation via inhibition of nuclear factor-kappaB and activator protein 1 activation in pigs.
Eur J Clin Invest. 2009 Mar;39(3):174-82. doi: 10.1111/j.1365-2362.2009.02089.x.
2
Nf-kappab and AP-1 activation is associated with late lumen loss after porcine coronary angioplasty and antiproliferative beta-irradiation.核因子κB和活化蛋白-1的激活与猪冠状动脉血管成形术和抗增殖β射线照射后的晚期管腔丢失有关。
Cardiovasc Res. 2007 Jul 1;75(1):195-204. doi: 10.1016/j.cardiores.2007.03.013. Epub 2007 Mar 16.
3
Prolonged application of clopidogrel reduces inflammation after percutaneous coronary intervention in the porcine model.在猪模型中,氯吡格雷的长期应用可减轻经皮冠状动脉介入术后的炎症反应。
Cardiovasc Revasc Med. 2007 Jul-Sep;8(3):183-8. doi: 10.1016/j.carrev.2007.03.003.
4
Effect of aspirin plus clopidogrel on inflammatory markers in patients with non-ST-segment elevation acute coronary syndrome.阿司匹林联合氯吡格雷对非ST段抬高型急性冠脉综合征患者炎症标志物的影响。
Chin Med J (Engl). 2006 Jan 5;119(1):32-6.
5
Mechanisms of late lumen loss after antiproliferative percutaneous coronary intervention using beta-irradiation in a porcine model of restenosis.在猪再狭窄模型中使用β射线进行抗增殖经皮冠状动脉介入治疗后晚期管腔丢失的机制。
Cardiovasc Revasc Med. 2007 Apr-Jun;8(2):94-8. doi: 10.1016/j.carrev.2006.10.004.
6
The long-term cost-effectiveness of clopidogrel plus aspirin in patients undergoing percutaneous coronary intervention in Sweden.氯吡格雷联合阿司匹林用于瑞典接受经皮冠状动脉介入治疗患者的长期成本效益分析
Clin Ther. 2005 Jan;27(1):100-10. doi: 10.1016/j.clinthera.2005.01.008.
7
Benefits and risks of clopidogrel use in patients with coronary artery disease: evidence from randomized studies and registries.氯吡格雷用于冠心病患者的获益与风险:来自随机研究和注册登记研究的证据
Clin Ther. 2008;30 Pt 2:2191-202. doi: 10.1016/j.clinthera.2008.12.001.
8
A high maintenance dose of clopidogrel improves short-term clinical outcomes in patients with acute coronary syndrome undergoing drug-eluting stent implantation.高维持剂量氯吡格雷可改善接受药物洗脱支架植入的急性冠状动脉综合征患者的短期临床结局。
Chin Med J (Engl). 2009 Apr 5;122(7):793-7.
9
Bleeding risk associated with 1 year of dual antiplatelet therapy after percutaneous coronary intervention: Insights from the Clopidogrel for the Reduction of Events During Observation (CREDO) trial.经皮冠状动脉介入治疗后1年双联抗血小板治疗的出血风险:来自氯吡格雷用于减少观察期事件(CREDO)试验的见解。
Am Heart J. 2009 Feb;157(2):369-74. doi: 10.1016/j.ahj.2008.09.011. Epub 2008 Nov 1.
10
Comparison of the impact of short (<1 year) and long-term (> or =1 year) clopidogrel use following percutaneous coronary intervention on mortality.经皮冠状动脉介入治疗后短期(<1年)和长期(≥1年)使用氯吡格雷对死亡率影响的比较。
Am J Cardiol. 2008 Nov 1;102(9):1159-62. doi: 10.1016/j.amjcard.2008.06.058. Epub 2008 Sep 11.

引用本文的文献

1
How selective antagonists and genetic modification have helped characterise the expression and functions of vascular P2Y receptors.选择性拮抗剂和基因改造如何有助于表征血管P2Y受体的表达和功能。
Purinergic Signal. 2025 Feb;21(1):11-22. doi: 10.1007/s11302-024-10016-z. Epub 2024 May 13.
2
Research progress of NF-κB signaling pathway and thrombosis.NF-κB 信号通路与血栓的研究进展。
Front Immunol. 2023 Sep 29;14:1257988. doi: 10.3389/fimmu.2023.1257988. eCollection 2023.
3
Ticagrelor and clopidogrel suppress NF-κB signaling pathway to alleviate LPS-induced dysfunction in vein endothelial cells.
替格瑞洛和氯吡格雷抑制 NF-κB 信号通路减轻 LPS 诱导的静脉内皮细胞功能障碍。
BMC Cardiovasc Disord. 2019 Dec 30;19(1):318. doi: 10.1186/s12872-019-01287-1.
4
Role of NF-κB in Platelet Function.NF-κB 在血小板功能中的作用。
Int J Mol Sci. 2019 Aug 27;20(17):4185. doi: 10.3390/ijms20174185.
5
Changes in inflammatory biomarkers in patients treated with ticagrelor or clopidogrel.替格瑞洛或氯吡格雷治疗患者的炎症生物标志物变化。
Clin Cardiol. 2010 Apr;33(4):206-12. doi: 10.1002/clc.20732.